Landos Biopharma, Inc.
PLXDC2 LIGANDS

Last updated:

Abstract:

Provided are compounds that target plexin domain containing 2 (PLXDC2). The compounds can be used to treat conditions such as inflammatory or immune-mediated diseases, diabetes, infectious diseases, and cancers. The compounds can be used to treat such specific conditions as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, autoimmune encephalitis, diabetic nephropathy, diabetic retinopathy, psoriasis, and inflammatory bowel disease, among other conditions.

Status:
Application
Type:

Utility

Filling date:

29 Sep 2021

Issue date:

20 Jan 2022